Tumor necrosis factor α as a new target for renal cell carcinoma : two sequential phase II trials of infliximab at standard and high dose
Data(s) |
01/01/2007
|
---|---|
Identificador | |
Idioma(s) |
eng |
Publicador |
American Society of Clinical Oncology |
Relação |
http://dro.deakin.edu.au/eserv/DU:30052314/hall-tumornecrosis-2007.pdf http://dx.doi.org/10.1200/JCO.2007.11.2136 |
Tipo |
Journal Article |